Results 171 to 180 of about 34,845 (214)
Mass spectrometry‐based phosphoproteomics for mechanistic dissection of cancer signaling pathways and uncovering therapeutic vulnerabilities. ABSTRACT Protein phosphorylation is a central post‐translational modification regulating cellular signaling, frequently dysregulated in cancer.
Hirokazu Shoji +2 more
wiley +1 more source
Characteristics, Prognosis and Reasons for Opting-Out of Treatment in Patients with Untreated Pancreatic Cancer. [PDF]
Ladekarl M, Stender MT.
europepmc +1 more source
Validation of Digital Cytology for Primary Diagnosis Across a Range of Specimen Types
This single‐centre validation study demonstrated strong diagnostic concordance between high‐resolution whole‐slide imaging and traditional light microscopy across diverse cytology specimen types. Even with limited prior experience, pathologists found digital cytology feasible and acceptable for diagnostic use.
Talisa Mistry +8 more
wiley +1 more source
Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot study. [PDF]
Eikenboom EL +14 more
europepmc +1 more source
Cadaveric addendum to the consensus on ultrasound‐based lymph‐node staging in gynecological cancer
Ultrasound in Obstetrics &Gynecology, EarlyView.
D. Fischerova +13 more
wiley +1 more source
Banting memorial lecture 2025: Aligning clinical practice, policy and research
Abstract National clinical leadership, on a background of clinical practice and clinical research, provides unique perspectives. I have focused the Banting Memorial Lecture 2025 on the implementation of national programmes across England since 2013, for which, along with colleagues at NHS England, I successfully made the case for investment, led the ...
Jonathan Valabhji
wiley +1 more source
From radiomics to transformers in pancreatic cancer detection and prognosis. [PDF]
Almufareh MF +6 more
europepmc +1 more source
Abstract Metabolic dysfunction‐associated steatotic liver disease (MASLD), characterised by hepatic steatosis and metabolic dysfunction (i.e., obesity, type 2 diabetes, dyslipidaemia, and hypertension), is affecting over 30% of the adult population worldwide.
Lanlan Chen, Paul Horn, Frank Tacke
wiley +1 more source

